Browsing Tag
Macular Degeneration
2 posts
Positive Interim Data Boosts 4D Molecular Therapeutics’ Shares
Shares of 4D Molecular Therapeutics surged by 76% to $30.83 following the company’s announcement of positive interim data…
Outlook Therapeutics Faces Setback as FDA Rejects ONS-5010 Treatment
Shares of Outlook Therapeutics (OTLK) took a nosedive in premarket trading today, plummeting over 60%. This significant drop…